Premium
P4‐185: UP‐TITRATION TO HIGH‐DOSE 13.3 MG/24 H RIVASTIGMINE TRANSDERMAL PATCH MAY PROVIDE GREATER BENEFIT TO ALZHEIMER'S DISEASE PATIENTS COMPARED TO CONCOMITANT USE OF 9.5 MG/24 H PATCH AND MEMANTINE: RESULTS FROM THE OPTIMA STUDY
Author(s) -
Molinuevo José L.,
Cummings Jeffrey,
Frolich Lutz,
Galvin James E.,
Krahnke Tillmann,
Strohmaier Christine
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1702
Subject(s) - memantine , rivastigmine , medicine , adverse effect , transdermal patch , concomitant , dementia , donepezil , anesthesia , pharmacology , transdermal , disease